SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149520
Filing Date
2023-05-19
Accepted
2023-05-19 17:21:03
Documents
13
Period of Report
2023-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d494976d8k.htm   iXBRL 8-K 49571
5 GRAPHIC g494976g0520013246826.jpg GRAPHIC 9081
  Complete submission text file 0001193125-23-149520.txt   194390

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nbix-20230517.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20230517_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20230517_pre.xml EX-101.PRE 10818
7 EXTRACTED XBRL INSTANCE DOCUMENT d494976d8k_htm.xml XML 3270
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 23941571
SIC: 2836 Biological Products, (No Diagnostic Substances)